147 related articles for article (PubMed ID: 11490352)
1. Immunogenicity of L(d+) transgenic mouse hearts.
Margenthaler JA; Tu F; Otomo N; Shimizu Y; Yu S; Flye MW
Surgery; 2001 Aug; 130(2):217-24. PubMed ID: 11490352
[TBL] [Abstract][Full Text] [Related]
2. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
3. Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
Margenthaler JA; Kataoka M; Flye MW
Transpl Immunol; 2004 Jan; 12(2):133-41. PubMed ID: 14967311
[TBL] [Abstract][Full Text] [Related]
4. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
5. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
7. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
Margenthaler JA; Kataoka M; Flye MW
Transplantation; 2003 Jun; 75(12):2119-27. PubMed ID: 12829922
[TBL] [Abstract][Full Text] [Related]
9. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
10. De novo-developed T cells have compromised response to existing alloantigens: using Ld-specific transgenic 2C T cells as tracers in a mouse heart transplantation model.
Luo H; Chen H; Qi S; Loh D; Daloze P; Veillette A; Xu D; Wu J
J Immunol; 1998 Jul; 161(1):73-82. PubMed ID: 9647209
[TBL] [Abstract][Full Text] [Related]
11. Activation and migration of allo-peptide specific TCR transgenic T cells in cardiac allograft rejection.
Honjo K; Xu XY; Kapp JA; Bucy RP
Cell Immunol; 2004 Jul; 230(1):44-55. PubMed ID: 15541718
[TBL] [Abstract][Full Text] [Related]
12. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
13. CD27/CD70, CD134/CD134 ligand, and CD30/CD153 pathways are independently essential for generation of regulatory cells after intratracheal delivery of alloantigen.
Aramaki O; Shirasugi N; Akiyama Y; Shibutani S; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Okumura K; Yagita H; Niimi M
Transplantation; 2003 Sep; 76(5):772-6. PubMed ID: 14501851
[TBL] [Abstract][Full Text] [Related]
14. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
15. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
[TBL] [Abstract][Full Text] [Related]
16. Transgene number-dependent, gene expression rate-independent rejection of Dd -, Kd-, or Dd Kd -transgened mouse skin or tumor cells from C57BL/6 Db Kb mice.
Inoue Y; Tashiro-Yamaji J; Hayashi M; Kiyonari H; Shimizu T; Ibata M; Yamana H; Kubota T; Tanigawa N; Yoshida R
Microbiol Immunol; 2011 Jun; 55(6):446-53. PubMed ID: 21434990
[TBL] [Abstract][Full Text] [Related]
17. A novel model of allograft rejection: immune reconstitution of Rag-1 recipients with 2C transgenic T-cell receptor lymphocytes.
Ninova D; Dean PG; Deeds M; Stegall MD
Transpl Int; 2005 Jan; 18(1):101-10. PubMed ID: 15612991
[TBL] [Abstract][Full Text] [Related]
18. [Expression of non-T cell derived cytokines in acute rejection after heart transplantation: experiment with mouse model].
Liang TB; Yu ZY; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):26-30. PubMed ID: 16606531
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice.
Stremmel C; Sienel W; Eggeling S; Passlick B; Slavin A
Eur J Cardiothorac Surg; 2006 Aug; 30(2):362-9. PubMed ID: 16828564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]